The impact of maintenance oral corticosteroids (OCS) on disease burden and type-2 inflammatory signal in the Wessex Severe Asthma Cohort (WSAC)
L. Wiffen (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Fox (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), S. Elliott (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom)
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Session: Personalised treatment of obstructive diseases
Session type: E-poster session
Number: 2678
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Wiffen (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Fox (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), S. Elliott (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom). The impact of maintenance oral corticosteroids (OCS) on disease burden and type-2 inflammatory signal in the Wessex Severe Asthma Cohort (WSAC). 2678
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: